After imposing a pause in November 2020, the U.S. Food and Drug Administration has cleared the way for a clinical trial of a gene therapy for Angelman syndrome.

The post Paused Angelman syndrome trial to restart appeared first on Spectrum | Autism Research News.

In this edition of Null and Noteworthy, tests of intranasal oxytocin and an Angelman syndrome treatment fail to see results.

The post Null and Noteworthy: Null rejection, repetitive behaviors, unsuccessful treatments appeared first on Spectrum | Autism Research News.

As treatments for some autism-linked genetic conditions inch closer to the clinic, researchers are talking more urgently about screening all newborns for such conditions.

The post The push to screen newborns for rare autism-linked genetic conditions appeared first on Spectrum | Autism Research News.

Here we explore the research on the cerebellum and its particular functioning in autism, and how this affects motor control and cognitive functions.